Streetbeat News

Price Targets

TXRH

Stephens & Co. analyst Joshua Long maintains an Equal-Weight rating on Texas Roadhouse (NASDAQ:TXRH) and raises the price target from $112 to $115.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 10:45 am

ADTH

Needham analyst Laura Martin has reiterated a 'Buy' rating on AdTheorent Holding (NASDAQ:ADTH) and maintained a price target of $3.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 10:44 am

ILLM

Needham analyst Laura Martin has reiterated a 'Buy' rating on Illumin Holdings (NASDAQ:ILLM) and maintained a price target of $2.5.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 10:43 am

QSR

Stephens & Co. analyst Joshua Long maintains an Equal-Weight rating on Restaurant Brands Intl (NYSE:QSR) and raises the price target from $72 to $77.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 10:42 am

SBUX

Stephens & Co. analyst Joshua Long maintains an Equal-Weight rating on Starbucks (NASDAQ:SBUX) and raises the price target from $103 to $110.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 10:40 am

MCD

Stephens & Co. analyst Joshua Long maintains an Overweight rating on McDonald's (NYSE:MCD) and raises the price target from $300 to $325.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 10:40 am

DPZ

Stephens & Co. analyst Joshua Long has maintained an Equal-Weight rating on Domino's Pizza (NYSE:DPZ) and raised the price target from $300 to $365.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 10:37 am

ACAD

HC Wainwright & Co. analyst Andrew Fein maintains a 'Buy' rating on ACADIA Pharmaceuticals and raises the price target from $28 to $33.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 10:17 am

APDN

HC Wainwright & Co. analyst Yi Chen has reiterated a 'Buy' rating on Applied DNA Sciences (NASDAQ:APDN) and maintained a $5 price target.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 10:15 am

AEZS

HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a 'Buy' rating on AEterna Zentaris (NASDAQ:AEZS) and maintained a $28 price target.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 10:14 am